Intended for healthcare professionals

Minerva

Vaccination for pneumococcal disease . . . and other stories

BMJ 2019; 364 doi: https://doi.org/10.1136/bmj.k5316 (Published 03 January 2019) Cite this as: BMJ 2019;364:k5316

Pneumococcal disease

There’s little doubt that vaccination has reduced the incidence of invasive pneumococcal disease and pneumonia in children. Data from Israel show that it has also led to a substantial decline in pneumococcal disease in unvaccinated adults (Am J Epidemiol doi:10.1093/aje/kwy219). This is probably because the main reservoir for the transmission of pneumococcus is the nasopharynx of young children and vaccination reduces the number of children who are colonised. Judged by reduction in burden of disease, this indirect protection in adults far outweighs the direct benefits in …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription